No large population study has demonstrated that Rh-negative blood, on its own, shortens or lengthens a person’s lifespan. The question keeps surfacing because researchers have found scattered differences between Rh-positive and Rh-negative people across a surprising range of health conditions, from infection outcomes and cancer prognosis to clotting speed and mental health. Individually, these findings are too small or too preliminary to change anyone’s life-expectancy estimate, but taken together they paint a genuinely interesting picture of a blood group marker that does more than sit quietly on the surface of red blood cells.
Why There Is No Simple Answer
Life expectancy is shaped by hundreds of interacting factors: genetics, diet, environment, access to healthcare, behavior. Isolating one blood group antigen from that tangle is extremely difficult. Most studies linking Rh status to health outcomes are observational, meaning they can spot associations but cannot prove that being Rh-negative caused any particular result. Sample sizes are often modest, findings frequently conflict across populations, and many studies were never designed to measure lifespan at all. What we have instead is a patchwork of condition-specific evidence, some favoring Rh-negative people, some favoring Rh-positive people, and much of it carrying caveats about needing replication.
Rh Status and Infectious Disease
The COVID-19 pandemic generated an unusually large body of evidence on blood type and infection. Several studies found that Rh-negative individuals were less likely to test positive for SARS-CoV-2 and, when infected, appeared to have a lower risk of severe illness and death compared to Rh-positive individuals. One large analysis estimated that Rh-negative people had roughly a 20 percent lower chance of being diagnosed with the virus and about an 18 percent lower risk of severe outcomes.1PubMed Central. Relationship between blood type and outcomes following COVID-19 infection A review of multiple studies came to a similar broad conclusion, noting that Rh-positive individuals appeared prone to more severe infection and complications, though it also emphasized that some studies cast doubt on the link and the underlying mechanisms remain unclear.2PubMed Central. Effects of ABO blood groups and RH-factor on COVID-19 transmission, course and outcome: A review
Not every study agreed. A study of Egyptian COVID-19 patients found no statistically significant association between Rh type and disease severity, even though it did find links between certain ABO blood groups and outcomes.3PubMed Central. Association of ABO/Rh Blood Groups and ABO Gene Variants rs8176746 and rs495828 with COVID-19 Severity Among Egyptian Patients This kind of inconsistency is a recurring theme in blood-group research: a trend shows up in one population and weakens or vanishes in another.
Beyond COVID-19, some of the most intriguing findings involve the parasite Toxoplasma gondii, which infects a substantial fraction of the world’s population and typically causes no obvious symptoms. Czech researchers have found that Rh-negative people who carry a latent Toxoplasma infection seem to be affected differently than Rh-positive carriers. In one study, Toxoplasma-positive Rh-negative subjects scored differently on intelligence tests than Toxoplasma-positive Rh-positive subjects, with the correlation between infection and lower cognitive performance being much stronger in the Rh-negative group.4PLoS ONE. Toxoplasmosis-Associated Difference in Intelligence and Personality in Men Depends on Their Rhesus Blood Group but Not ABO Blood Group Another study found that Toxoplasma infection was associated with reduced grip strength and endurance in Rh-negative subjects but not in Rh-positive ones, where it sometimes had a slight positive association with endurance.5PubMed Central. Lower performance of Toxoplasma-infected, Rh-negative subjects in the weight holding and hand-grip tests The takeaway is not that Rh-negative blood makes Toxoplasma more dangerous per se, but that Rh status appears to modify how the body responds to this particular parasite, and the Rh-negative group seems more vulnerable to its subtle effects.
Cancer Prognosis and Rh Factor
A handful of studies have looked at whether Rh status influences cancer outcomes, and the early signals are mixed but leaning slightly in favor of Rh-negative patients for certain cancers. A nationwide retrospective study of nearly 4,000 breast cancer patients in Turkey found that Rh-positive patients had significantly higher rates of distant metastasis and lobular breast cancer compared to Rh-negative patients. After adjusting for other variables, Rh-positive patients had about 1.6 times the risk of distant metastasis.6PubMed Central. Clinical Associations with ABO Blood Group and Rhesus Blood Group Status in Patients with Breast Cancer Similarly, a study of cervical cancer patients found that Rh-negative patients were diagnosed at a younger age but had higher overall survival than Rh-positive patients, though the researchers themselves cautioned that the statistical significance was weak and larger studies would be needed to confirm the pattern.7PubMed Central. ABO/Rh Blood Group and Cervical Cancer Survival: Results from Our Own and Other Studies
These are intriguing findings, but they represent specific cancer types in specific populations. No one has shown a consistent, across-the-board cancer advantage for Rh-negative people. And in other cancers, the story shifts toward ABO blood type rather than Rh factor. A study of small-cell lung cancer, for example, found that ABO blood group interacted with systemic inflammation markers to predict treatment response, with blood groups A, B, and AB all showing worse odds compared to group O. Rh status was not the driving factor in that analysis.8PubMed Central. Prognostic Impact of ABO/Rh Blood Group–Systemic Inflammation Indices Interactions in Small-Cell Lung Cancer The broader lesson is that when people talk about “blood type and cancer,” ABO differences tend to carry more weight in the research literature than Rh differences.
Blood Clotting Differences
One of the more concrete biological differences between Rh-positive and Rh-negative people involves blood clotting. A recent study measuring standard coagulation tests found that Rh-positive individuals had slightly longer prothrombin times and activated partial thromboplastin times compared to Rh-negative individuals, differences of about one to two seconds on average.9PubMed Central. Classic Coagulation Traits Vary According to Rh(D) (But Not ABO) Blood Groups In plain terms, Rh-positive blood clotted a touch more slowly than Rh-negative blood in these lab tests. Whether that translates to a meaningful real-world difference in heart attack or stroke risk is unknown, but it does suggest the Rh antigen is not biologically inert when it comes to hemostasis.
For cardiovascular disease more broadly, the much-studied risk factor is ABO blood type rather than Rh. The large REGARDS study, which followed thousands of participants for nearly six years, found that ABO blood type AB was associated with a higher risk of stroke compared to type O, but types A and B were not. That study’s findings were about ABO grouping, not Rh.10Journal of Thrombosis and Haemostasis. ABO Blood Type and Stroke Risk: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study So if you are Rh-negative and worried about heart disease or stroke, your ABO type and your lifestyle habits matter far more than your Rh status based on current evidence.
Autoimmune and Metabolic Conditions
Some data link Rh-positive status with a somewhat higher prevalence of certain autoimmune conditions. In a study of patients with lupus and rheumatoid arthritis, arthritis was more common in Rh-positive patients than Rh-negative ones.11PubMed Central. ABO and Rh blood groups in patients with lupus and rheumatoid arthritis A separate study of patients with various rheumatic diseases found that over 92 percent were Rh-positive, a higher proportion than typically seen in the general population, suggesting a skew toward Rh-positive individuals among people with these disorders.12PubMed Central. ABO blood groups and rheumatic diseases These are small studies that cannot prove causation, but they add another data point suggesting Rh status is not entirely irrelevant to immune function.
Type 2 diabetes presents an interesting case. A study from Saudi Arabia found that Rh-negative individuals were roughly three times less common among diabetic patients than in the general population, suggesting a possible protective association.13Integrative Obesity and Diabetes. Distribution of ABO and Rhesus (Rh) blood group antigens in male type 2 diabetes mellitus patients in Hail region of Saudi Arabia That sounds dramatic, but a systematic review and meta-analysis that pooled data from multiple studies found no significant association between Rh blood group and type 2 diabetes overall.14PubMed Central. Relationships of ABO and Rhesus blood groups with type 2 diabetes mellitus: a systematic review and meta-analysis This is a textbook example of why single studies, even ones with striking numbers, can be misleading. When you gather the broader evidence, the signal evaporates. The meta-analysis found essentially no heterogeneity among the pooled studies, which is a strong indication that the Saudi finding was an outlier rather than a hidden truth.
Mental Health and Self-Reported Wellbeing
Rh-negative people report worse overall health in surveys, though the reasons are debated. A large Czech study found that Rh-negative subjects reported more frequent problems across several categories: allergic, digestive, cardiac, hematological, immunological, mental health, and neurological issues.15PubMed Central. Worse Health Status and Higher Incidence of Health Disorders in Rhesus Negative Subjects Another study found that Rh-negative women reported lower quality of life and worse economic situations, while Rh-negative men reported worse mental health, worse economic situations, and fewer children.16PLoS ONE. Rhesus-minus phenotype as a predictor of sexual desire and behavior, wellbeing, mental health, and fecundity
A study of medical and physical therapy students found a curious pattern: Rh-positive students tended toward more severe anxiety but milder depression, while Rh-negative students tended toward milder anxiety but more severe depression.17PubMed Central. Anxiety and depression among various blood groups of undergraduate medical and physical therapy students This is one of those findings that sounds tidy but should be taken with a grain of salt, given that it was a small survey of students in a single academic program.
The honest assessment of this body of evidence is that it is real but hard to interpret. Self-reported health is influenced by personality, awareness, and culture. It is possible that Rh-negative people genuinely experience more health problems. It is also possible that unmeasured confounders, perhaps related to the same genetic region or to population structure, explain the pattern. And the Czech research group responsible for many of these findings has been upfront about the need for replication in other populations.
The Pregnancy Complication That Transformed Obstetric Medicine
The most medically significant consequence of Rh-negative blood has nothing to do with the person who carries it and everything to do with their potential children. When an Rh-negative mother carries an Rh-positive fetus, her immune system can develop antibodies against the baby’s red blood cells, a condition called hemolytic disease of the fetus and newborn. Before modern prevention was available, this was a major cause of stillbirth and neonatal death.18PubMed Central. Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children
The introduction of anti-D immunoglobulin injections in the late 1960s was one of the great public health victories of the twentieth century. Given both during pregnancy and after delivery, the treatment is about 99 percent effective at preventing the mother’s immune system from sensitizing against Rh-positive blood cells.18PubMed Central. Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children Modern protocols using routine antenatal anti-D prophylaxis have drastically reduced the severe complications that once made Rh-negative pregnancy genuinely dangerous, including hydrops fetalis and severe hyperbilirubinemia.19International Journal of Science and Research Archive. Feto-maternal outcome of Rh-Negative pregnancy presenting in a tertiary healthcare centre In countries with reliable access to this treatment, the once-feared Rh disease is now rare. In parts of the world where anti-D prophylaxis is inconsistently available, it still causes preventable deaths.
For the question of whether Rh-negative blood affects your own life expectancy, this piece of biology is mostly about your offspring rather than you. But historically, before immunoprophylaxis, Rh-negative women in Rh-positive-dominant populations did face repeated pregnancy losses, which in a population-level sense reduced reproductive fitness. That raises an interesting evolutionary question.
Why Rh-Negative Blood Persists at All
About 15 percent of people of European descent are Rh-negative. The frequency is much lower in Asian and African populations. Given that Rh-negative status creates a potential reproductive disadvantage through hemolytic disease, you might expect natural selection to have driven it to extinction long ago. Researchers have explored whether there might be some hidden health benefit to being Rh-negative that balances out the reproductive cost, similar to how the sickle cell trait persists because it protects against malaria.
A genomic analysis using data from multiple population samples tested this idea directly and found no evidence that positive natural selection had driven the Rh-negative deletion to its current frequency. Instead, the researchers concluded that the initial rise of the Rh-negative variant in European populations could be explained by genetic drift or a founder effect, basically chance events in small ancestral populations. Their simulations also showed that once the deletion reached a middling frequency, the selective pressure against it becomes very weak, meaning it could persist at its current level with only a small amount of random fluctuation.20PubMed Central. Evolutionary genetics of the human Rh blood group system In other words, the persistence of Rh-negative blood may not require a health advantage to explain it. It might just be a quirk of population history that is now self-sustaining.
What the Rh Protein Actually Does
Part of what makes the Rh question so hard to settle is that we are still learning what the Rh proteins do beyond carrying a blood group antigen. Laboratory work has shown that the Rh-associated glycoprotein on red blood cells functions as a transporter for ammonium ions, moving them across cell membranes in a process coupled to hydrogen ion gradients.21PubMed. Identification of the erythrocyte Rh blood group glycoprotein as a mammalian ammonium transporter Ammonium transport is important for maintaining acid-base balance and for kidney function. This means the Rh system is not just a label for blood typing; it plays an active physiological role. Whether the absence of the RhD protein in Rh-negative people meaningfully alters this transport is still an open question, but it provides a plausible biological mechanism through which Rh status could influence health in ways we have not yet fully mapped.
Emergency Transfusion and Practical Implications
If you are Rh-negative, one area where your blood type has concrete, immediate practical relevance is emergency medicine. In trauma situations where there is no time for blood typing, hospitals typically reach for O-negative blood as the universal donor. But O-negative blood is relatively scarce, making up only about 7 percent of the blood supply in many countries. When it runs short, Rh-positive blood may be given to Rh-negative patients as a calculated risk.
For most patients in hemorrhagic shock, receiving Rh-positive blood when you are Rh-negative does not cause an immediate life-threatening reaction on the first exposure. The concern is sensitization: your immune system may develop anti-D antibodies that could complicate future transfusions or pregnancies. Research has supported the safety and utility of giving Rh-positive blood products in emergency settings, particularly when the alternative is the patient dying from blood loss.22PubMed. RhD-Positive Transfusion in Females of Childbearing Potential in Hemorrhagic Shock: Risk, Reality, and Policy For Rh-negative women of childbearing age, this creates a more nuanced clinical decision, since sensitization could lead to hemolytic disease in a future pregnancy. Protocols vary by institution, but the trend in emergency medicine has been toward accepting Rh-positive blood when Rh-negative is unavailable, while flagging the patient for follow-up care.
In one study of trauma patients receiving emergency uncrossmatched transfusions, about a third of patients died, mostly within the first day and from their injuries rather than from transfusion reactions.23PubMed. Emergency uncrossmatched transfusion effect on blood type alloantibodies The point is that in life-or-death trauma, blood type mismatches rank well below hemorrhage on the list of things that kill you. Being Rh-negative does not put you at meaningfully higher risk in a trauma scenario as long as a hospital follows standard protocols.
Separating Signal From Noise
One of the trickiest aspects of this entire topic is that Rh status is often studied alongside ABO type, and the two get tangled in reporting. Many headlines about “blood type and disease risk” are actually about ABO differences, with Rh as an afterthought in the analysis. The REGARDS stroke study, for instance, found a real association between blood type AB and stroke risk, but Rh had nothing to do with it.10Journal of Thrombosis and Haemostasis. ABO Blood Type and Stroke Risk: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study When someone tells you “your blood type affects your risk of X,” it is worth asking which part of the blood type they mean.
The other common source of confusion is the volume of pseudoscientific claims that have attached themselves to Rh-negative blood over the years, from alien ancestry theories to special diets based on blood type. None of this has any scientific support. What is real is that Rh status appears to subtly modify risk for a handful of conditions, that these effects are generally small and population-dependent, and that the Rh protein has genuine biological functions beyond blood typing that we are still working to understand. If you are Rh-negative, you are not a member of a mysterious lineage, but you are carrying a genetic variant with real, if modest, physiological consequences that science has not yet finished cataloging.